Articles from Signature Biologics
Signature Biologics Warns Public About Unauthorized Use of Chairman Dr. Neil Riordan's Name and Likeness
Signature Biologics, LLC, an Irving-based developer and manufacturer of cellular and biologic products, is warning patients and the public that unaffiliated businesses are using the name, photograph and video content of its founder and chairman, Dr. Neil Riordan, without his or the company’s knowledge or consent and in a false and misleading way, to promote their own stem cell products and services.
By Signature Biologics · Via Business Wire · November 10, 2026
FDA Allows Expanded Enrollment in Clinical Study of Signature Biologics’ Investigational Cell Therapy for Duchenne Muscular Dystrophy
Signature Biologics, a clinical-stage cell therapy company committed to rigorous clinical research and to the DMD community, today announced that the U.S. Food and Drug Administration (FDA) has allowed expanded enrollment in a clinical study of the company’s investigational umbilical cord–derived mesenchymal stem cell (UC-MSC) therapy in subjects with Duchenne muscular dystrophy (DMD).
By Signature Biologics · Via Business Wire · August 11, 2026